Profile
Dr. Andrew Saunders, MD, is a Chief Medical Officer at Captor Therapeutics SA and a Chief Medical Officer at CellCentric Ltd. Dr. Saunders was previously employed as a Chief Medical Officer by Redx Pharma Plc, a Chief Medical Officer by Lytix Biopharma AS, a Chief Medical Officer by Bioenvision, Inc., and a Managing Director by Linden Oncology Ltd. He received his doctorate degree from Trinity College Dublin.
Andrew Saunders active positions
| Companies | Position | Start |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Chief Tech/Sci/R&D Officer | 01/03/2024 |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule inhibitors for cancer | Chief Tech/Sci/R&D Officer | - |
Former positions of Andrew Saunders
| Companies | Position | End |
|---|---|---|
| REDX PHARMA LIMITED | Chief Tech/Sci/R&D Officer | 01/03/2021 |
| LYTIX BIOPHARMA ASA | Chief Tech/Sci/R&D Officer | 01/12/2017 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Chief Tech/Sci/R&D Officer | 09/04/2007 |
Linden Oncology Ltd. | Chief Executive Officer | - |
Training of Andrew Saunders
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Trinity College Dublin
Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule inhibitors for cancer | Health Technology |
Lytix Biopharma AS
Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Redx Pharma Plc
Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Linden Oncology Ltd. | |
Captor Therapeutics SA
Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Andrew Saunders
















